Advanced Biomed Inc. (NASDAQ:ADVB – Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 9,747 shares, a drop of 48.4% from the September 30th total of 18,897 shares. Based on an average daily volume of 16,412 shares, the short-interest ratio is presently 0.6 days. Approximately 0.8% of the shares of the stock are short sold.
Advanced Biomed Stock Down 12.9%
Shares of NASDAQ ADVB traded down $0.34 during mid-day trading on Friday, reaching $2.30. 21,780 shares of the company were exchanged, compared to its average volume of 38,334. Advanced Biomed has a 52 week low of $2.25 and a 52 week high of $24.23. The stock has a market capitalization of $3.79 million, a PE ratio of 0.48 and a beta of 0.01. The company’s 50 day moving average price is $6.52 and its 200 day moving average price is $5.91.
Advanced Biomed (NASDAQ:ADVB – Get Free Report) last released its earnings results on Tuesday, October 13th. The company reported $0.44 EPS for the quarter.
Analysts Set New Price Targets
A number of brokerages recently issued reports on ADVB. Weiss Ratings downgraded Advanced Biomed from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, October 8th. Wall Street Zen cut shares of Advanced Biomed from a “hold” rating to a “sell” rating in a research report on Saturday, October 17th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.
Read Our Latest Stock Analysis on ADVB
Advanced Biomed Company Profile
Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.
Recommended Stories
- Five stocks we like better than Advanced Biomed
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
- The Factories Behind AI Servers Just Raised Their Outlooks—3 Contract Manufacturers to Watch
Receive News & Ratings for Advanced Biomed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Biomed and related companies with MarketBeat.com's FREE daily email newsletter.
